Lessons learned from the transgenic Huntington's disease rats

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Huntington's disease (HD) is a fatal inherited neurodegenerative disorder with no current cure or effective symptom-reducing therapies.
• Animal models are crucial for investigating novel therapeutic strategies for HD.

Purpose of the Study:

• To review the utility of the first transgenic rat model of Huntington's disease in research.
• To analyze the behavioral, neurophysiological, and histopathological phenotype of this HD rat model.

Main Methods:

• Utilized a transgenic rat model carrying a truncated huntingtin cDNA fragment (51 CAG repeats).
• Evaluated the phenotype through behavioral tests, neurophysiological assessments, and histopathological analysis.
• Compared findings with existing literature on Huntington's disease models.

Main Results:

• The transgenic rat model displays a phenotype relevant to Huntington's disease.
• Observed specific behavioral deficits, neurophysiological alterations, and histopathological changes consistent with HD.
• This model provides a valuable platform for studying HD pathogenesis and testing interventions.

Conclusions:

• The transgenic rat model offers a robust platform for Huntington's disease research.
• Further investigation using this model can advance the development of treatments for HD.
• This review consolidates current knowledge on the model's phenotype for the scientific community.